Cognition Therapeutics INC 8-K Filing
Ticker: CGTX · Form: 8-K · Filed: Sep 15, 2025 · CIK: 1455365
| Field | Detail |
|---|---|
| Company | Cognition Therapeutics INC (CGTX) |
| Form Type | 8-K |
| Filed Date | Sep 15, 2025 |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Cognition Therapeutics INC (ticker: CGTX) to the SEC on Sep 15, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.001 (h Registered Common Stock, par value $0.001 per share CGTX The Nasdaq Stock Mar).
How long is this filing?
Cognition Therapeutics INC's 8-K filing is 1 pages with approximately 426 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 426 words · 2 min read · ~1 pages · Grade level 11.5 · Accepted 2025-09-15 07:00:54
Key Financial Figures
- $0.001 — h Registered Common Stock, par value $0.001 per share CGTX The Nasdaq Stock Mar
Filing Documents
- tm2525997d1_8k.htm (8-K) — 24KB
- tm2525997d1_ex99-1.htm (EX-99.1) — 61KB
- tm2525997d1_ex99-1img001.jpg (GRAPHIC) — 69KB
- tm2525997d1_ex99-1img002.jpg (GRAPHIC) — 283KB
- tm2525997d1_ex99-1img003.jpg (GRAPHIC) — 165KB
- tm2525997d1_ex99-1img004.jpg (GRAPHIC) — 148KB
- tm2525997d1_ex99-1img005.jpg (GRAPHIC) — 130KB
- tm2525997d1_ex99-1img006.jpg (GRAPHIC) — 182KB
- tm2525997d1_ex99-1img007.jpg (GRAPHIC) — 153KB
- tm2525997d1_ex99-1img008.jpg (GRAPHIC) — 85KB
- tm2525997d1_ex99-1img009.jpg (GRAPHIC) — 136KB
- tm2525997d1_ex99-1img010.jpg (GRAPHIC) — 131KB
- tm2525997d1_ex99-1img011.jpg (GRAPHIC) — 132KB
- tm2525997d1_ex99-1img012.jpg (GRAPHIC) — 114KB
- tm2525997d1_ex99-1img013.jpg (GRAPHIC) — 160KB
- tm2525997d1_ex99-1img014.jpg (GRAPHIC) — 119KB
- tm2525997d1_ex99-1img015.jpg (GRAPHIC) — 111KB
- tm2525997d1_ex99-1img016.jpg (GRAPHIC) — 167KB
- tm2525997d1_ex99-1img017.jpg (GRAPHIC) — 135KB
- tm2525997d1_ex99-1img018.jpg (GRAPHIC) — 145KB
- tm2525997d1_ex99-1img019.jpg (GRAPHIC) — 191KB
- tm2525997d1_ex99-1img020.jpg (GRAPHIC) — 150KB
- tm2525997d1_ex99-1img021.jpg (GRAPHIC) — 149KB
- tm2525997d1_ex99-1img022.jpg (GRAPHIC) — 125KB
- tm2525997d1_ex99-1img023.jpg (GRAPHIC) — 108KB
- tm2525997d1_ex99-1img024.jpg (GRAPHIC) — 133KB
- tm2525997d1_ex99-1img025.jpg (GRAPHIC) — 149KB
- tm2525997d1_ex99-1img026.jpg (GRAPHIC) — 141KB
- tm2525997d1_ex99-1img027.jpg (GRAPHIC) — 128KB
- tm2525997d1_ex99-1img028.jpg (GRAPHIC) — 123KB
- tm2525997d1_ex99-1img029.jpg (GRAPHIC) — 123KB
- tm2525997d1_ex99-1img030.jpg (GRAPHIC) — 157KB
- tm2525997d1_ex99-1img031.jpg (GRAPHIC) — 114KB
- tm2525997d1_ex99-1img032.jpg (GRAPHIC) — 125KB
- tm2525997d1_ex99-1img033.jpg (GRAPHIC) — 99KB
- tm2525997d1_ex99-1img034.jpg (GRAPHIC) — 123KB
- tm2525997d1_ex99-1img035.jpg (GRAPHIC) — 152KB
- tm2525997d1_ex99-1img036.jpg (GRAPHIC) — 133KB
- tm2525997d1_ex99-1img037.jpg (GRAPHIC) — 114KB
- tm2525997d1_ex99-1img038.jpg (GRAPHIC) — 164KB
- tm2525997d1_ex99-1img039.jpg (GRAPHIC) — 135KB
- tm2525997d1_ex99-1img040.jpg (GRAPHIC) — 136KB
- 0001104659-25-089737.txt ( ) — 7889KB
- cgtx-20250915.xsd (EX-101.SCH) — 3KB
- cgtx-20250915_lab.xml (EX-101.LAB) — 33KB
- cgtx-20250915_pre.xml (EX-101.PRE) — 22KB
- tm2525997d1_8k_htm.xml (XML) — 4KB
01 Other Events
Item 8.01 Other Events. Attached as Exhibit 99.1 is a presentation that the Company may use from time to time in presentations or discussions with investors, analysts, and other parties.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits The following exhibits are being furnished herewith: Exhibit No. Document 99.1 Investor presentation of Cognition Therapeutics, Inc. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. COGNITION THERAPEUTICS, INC. Date: September 15, 2025 By: /s/ Lisa Ricciardi Name: Lisa Ricciardi Title: President and Chief Executive Officer